Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials

OBJECTIVES: The objective of this study was to assess differences in efficacy outcomes between luteinizing hormone-releasing hormone (LHRH) agonist plus antiandrogen (AA) flare protection and monotherapy with the gonadotrophin-releasing hormone antagonist degarelix in patients with prostate cancer....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Urol
Main Authors: Iversen, Peter, Damber, Jan-Erik, Malmberg, Anders, Persson, Bo-Eric, Klotz, Laurence
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772358/
https://ncbi.nlm.nih.gov/pubmed/27034720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215621471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados